LONG READS → THE BEAT Issue 866 · June 23, 2021

Hatzalah’s Vaccine Survey: 5 Takeaways

Conducted over ten days at the end of April, the survey categorized respondents into three groups

Hatzalah’s Vaccine Survey: 5 Takeaways
The Backstory // Hatzalah’s Vaccine Survey: 5 Takeaways

The Hatzalah survey on vaccination trends in New York’s Orthodox community released this month was closely watched for what it said about a demographic that came under media fire at the height of the pandemic.

Conducted over ten days at the end of April, the survey categorized respondents into three groups: chassidish, of which nine kehillos provided 1,724 responses; yeshivish, which gave 1,212 responses; and Modern Orthodox, of whom 484 people answered.

I spoke to Rabbi Yehiel Kalish, the CEO of Chevra Hatzalah of New York, which sponsored the poll, and Moish Trencher, whose Nishma Research conducted it.

Here are five takeaways.

1. The chassidish kehillos may have had herd immunity last year

Continue reading with Mishpacha.

Create a free account to keep reading.

Everything you need to stay close to Mishpacha.
← Previous installment A Foot in Both Camps Next installment → Living Higher: A Brachah from Rav Wolfson